441 related articles for article (PubMed ID: 36071466)
1. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.
Chen Y; Yang W; Chen F; Cui L
J Neuroinflammation; 2022 Sep; 19(1):222. PubMed ID: 36071466
[TBL] [Abstract][Full Text] [Related]
2. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
3. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions.
Kempuraj D; Aenlle KK; Cohen J; Mathew A; Isler D; Pangeni RP; Nathanson L; Theoharides TC; Klimas NG
Neuroscientist; 2023 Sep; ():10738584231194927. PubMed ID: 37694571
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 mediates blood-brain barrier permeability, neuroinflammation, and cognitive impairment in SARS-CoV-2 infection.
Trevino TN; Almousawi AA; Robinson KF; Fogel AB; Class J; Minshall RD; Tai LM; Richner JM; Lutz SE
J Neuroimmunol; 2024 Mar; 388():578309. PubMed ID: 38335781
[TBL] [Abstract][Full Text] [Related]
7. Neuro-COVID-19: an insidious virus in action.
Bratosiewicz-Wąsik J
Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
[TBL] [Abstract][Full Text] [Related]
8. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 associated nervous system manifestations.
Khatoon F; Prasad K; Kumar V
Sleep Med; 2022 Mar; 91():231-236. PubMed ID: 34321155
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2: is there neuroinvasion?
McQuaid C; Brady M; Deane R
Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
[TBL] [Abstract][Full Text] [Related]
12. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
Li Z; Liu T; Yang N; Han D; Mi X; Li Y; Liu K; Vuylsteke A; Xiang H; Guo X
Front Med; 2020 Oct; 14(5):533-541. PubMed ID: 32367431
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
Hachem M
Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
[TBL] [Abstract][Full Text] [Related]
14. Neurological manifestations and pathogenic mechanisms of COVID-19.
Galea M; Agius M; Vassallo N
Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
Front Immunol; 2021; 12():697329. PubMed ID: 34386007
[TBL] [Abstract][Full Text] [Related]
16. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients.
Khan M; Clijsters M; Choi S; Backaert W; Claerhout M; Couvreur F; Van Breda L; Bourgeois F; Speleman K; Klein S; Van Laethem J; Verstappen G; Dereli AS; Yoo SJ; Zhou H; Dan Do TN; Jochmans D; Laenen L; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Meersseman P; Neyts J; Thal DR; Topsakal V; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
Neuron; 2022 Dec; 110(23):3919-3935.e6. PubMed ID: 36446381
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.
Qiao H; Deng X; Qiu L; Qu Y; Chiu Y; Chen F; Xia S; Muenzel C; Ge T; Zhang Z; Song P; Bonnin A; Zhao Z; Yuan W
J Med Virol; 2024 May; 96(5):e29671. PubMed ID: 38747003
[TBL] [Abstract][Full Text] [Related]
18. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and neurodegenerative diseases.
Fu YW; Xu HS; Liu SJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
[TBL] [Abstract][Full Text] [Related]
20. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain.
Dey J; Alam MT; Chandra S; Gupta J; Ray U; Srivastava AK; Tripathi PP
J Med Virol; 2021 Mar; 93(3):1296-1303. PubMed ID: 32964419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
